Y-mAbs Therapeutics, Inc.
Clinical cancer drug development
- B2B
About Y-mAbs Therapeutics, Inc.
A clinical biopharmaceutical company developing novel antibody-based cancer therapeutics to address unmet medical needs in pediatric and adult patients
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- New York, United States
- Founded
- 2015
- Revenue
- $87.7MFY2024, publicly reported
- Website
- ymabs.com
Y-mAbs Therapeutics, Inc. at a glance
Y-mAbs Therapeutics, Inc. is a B2B company in the Biotechnology Research industry, headquartered in New York, United States.
Y-mAbs Therapeutics, Inc. was founded in 2015.
Y-mAbs Therapeutics, Inc. has 51–250 employees.
Y-mAbs Therapeutics, Inc.'s revenue is $87.7M (FY2024, publicly reported).
Selling to companies like Y-mAbs Therapeutics, Inc.?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies